Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Search results for DTSA
What does the timing of the US Defend Trade Secrets Act and EU Trade Secrets Directive really mean for companies? What does the timing of the US Defend Trade Secrets Act and EU Trade Secrets Directive really mean for companies? Reviewed by Annsley Merelle Ward on Tuesday, May 24, 2016 Rating: 5
Fordham 33 (Report 5): Trade secrets Fordham 33 (Report 5): Trade secrets Reviewed by Annsley Merelle Ward on Tuesday, April 14, 2026 Rating: 5
The U.S. Defend Trade Secrets Act of 2015: What Are the Rationales? [Part 2] The U.S. Defend Trade Secrets Act of 2015: What Are the Rationales? [Part 2] Reviewed by Mike Mireles on Friday, March 18, 2016 Rating: 5
The U.S. Defend Trade Secrets Act of 2015: Will It Result in Enforcement Abuse? [Part 1] The U.S. Defend Trade Secrets Act of 2015: Will It Result in Enforcement Abuse? [Part 1] Reviewed by Mike Mireles on Wednesday, March 16, 2016 Rating: 5
Note from AmeriKat: US Senate passes Defend Trade Secrets Act, while patent legislation lingers in Congress Note from AmeriKat: US Senate passes Defend Trade Secrets Act, while patent legislation lingers in Congress Reviewed by Annsley Merelle Ward on Sunday, April 10, 2016 Rating: 5
Tomorrow's Senate Judiciary Committee hearing to tackle trade secrets theft Tomorrow's Senate Judiciary Committee hearing to tackle trade secrets theft Reviewed by Annsley Merelle Ward on Tuesday, December 01, 2015 Rating: 5
The Evolution of U.S. Law and the Bio-Pharmaceutical Industry The Evolution of U.S. Law and the Bio-Pharmaceutical Industry Reviewed by Mike Mireles on Wednesday, April 06, 2016 Rating: 5
Never too late: if you missed the IPKat last week Never too late: if you missed the IPKat last week Reviewed by Alberto Bellan on Tuesday, March 22, 2016 Rating: 5
Report on IPO’s 2018 European Practice Committee Conference (1/2) Report on IPO’s 2018 European Practice Committee Conference (1/2) Reviewed by Tian Lu on Saturday, May 26, 2018 Rating: 5
Trade secrets in the wild (Part 2): The reporting problem Trade secrets in the wild (Part 2): The reporting problem Reviewed by Neil Wilkof on Monday, May 03, 2021 Rating: 5
Never too late: if you missed the IPKat last week Never too late: if you missed the IPKat last week Reviewed by Eleonora Rosati on Monday, December 07, 2015 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.